Open consultation

Expanding access to naloxone: supply and emergency use

Summary

This consultation seeks views on proposals to make further legislative changes to expand access to take-home naloxone supplies and naloxone for emergency use.

This consultation closes at

Consultation description

Naloxone is a life-saving drug that reverses the effects of an opioid overdose and can help to prevent overdose deaths. Anyone can administer naloxone in an emergency but currently, it can only legally be supplied to an individual for future use by a list of professionals and services named in the Human Medicines Regulations 2012.

The Department of Health and Social Care is seeking views in this consultation on proposals to further expand access to naloxone across the UK.

Specifically, we are proposing to make further legislative changes to:

  • allow hostels, day centres and outreach services for people experiencing homelessness to supply naloxone without a prescription
  • create publicly accessible emergency naloxone boxes, similar to defibrillator cabinets
  • clarify rules for workplaces at risk of opioid contamination (accidental exposure)

The consultation document provides the public and people with experience or expertise in substance use disorders with further information about the proposed changes.

A draft statutory instrument is also attached, and we welcome comments on the detail that it provides about the potential changes. The outcomes of the consultation will inform and shape the draft statutory instrument, so the final version laid before the UK Parliament and the Northern Ireland Assembly may look different.  

Since the proposed changes to legislation would apply throughout the UK, this consultation applies to England, Wales, Scotland and Northern Ireland in conjunction with the Department of Health (Northern Ireland).

Documents

Draft Human Medicines (Amendments Relating to Naloxone) Regulations 2026

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dhsc.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Ways to respond

Updates to this page

Published 29 December 2025
Last updated 29 December 2025 href="#full-history">+ show all updates
  1. Updated to correct the number of deaths involving nitazenes in 2024 to 195, in line with the Office for National Statistics release ‘Deaths related to drug poisoning in England and Wales: 2024 registrations’.

  2. First published.

Sign up for emails or print this page